FI892386A0 - Menetelmä enantiomeeristen glutaarihappoamidipohjaisten virtsaneritystä lisäävien yhdisteiden valmistamiseksi - Google Patents

Menetelmä enantiomeeristen glutaarihappoamidipohjaisten virtsaneritystä lisäävien yhdisteiden valmistamiseksi

Info

Publication number: FI892386A0
Authority: FI; Finland
Prior art keywords: enantiomeric; preparation; acid amide; glutaric acid; urinary excretion
Prior art date: 1988-05-19

Application number

FI892386A

Other languages

English (en)

Swedish (sv)

Other versions

FI93541B (fi

FI892386L (fi

FI93541C (fi

Inventor

John Christopher Danilewicz

Michael Trevelyan Williams

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-19

Filing date

1989-05-18

Publication date

1989-05-18

1989-05-18 Application filed by Pfizer filed Critical Pfizer

1989-05-18 Publication of FI892386A0 publication Critical patent/FI892386A0/fi

1989-11-20 Publication of FI892386L publication Critical patent/FI892386L/fi

1995-01-13 Publication of FI93541B publication Critical patent/FI93541B/fi

1995-04-25 Application granted granted Critical

1995-04-25 Publication of FI93541C publication Critical patent/FI93541C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Detergent Compositions (AREA)
Hydrogenated Pyridines (AREA)
Cosmetics (AREA)

FI892386A 1988-05-19 1989-05-18 Menetelmä enantiomeeristen glutaarihappoamidipohjaisten virtsaneritystä lisäävien yhdisteiden valmistamiseksi FI93541C (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB888811873A GB8811873D0 (en)	1988-05-19	1988-05-19	Therapeutic agents
GB8811873		1988-05-19

Publications (4)

Publication Number	Publication Date
FI892386A0 true FI892386A0 (fi)	1989-05-18
FI892386L FI892386L (fi)	1989-11-20
FI93541B FI93541B (fi)	1995-01-13
FI93541C FI93541C (fi)	1995-04-25

Family

ID=10637176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI892386A FI93541C (fi)	1988-05-19	1989-05-18	Menetelmä enantiomeeristen glutaarihappoamidipohjaisten virtsaneritystä lisäävien yhdisteiden valmistamiseksi

Country Status (29)

Country	Link
EP (1)	EP0342850B1 (fi)
JP (1)	JPH072699B2 (fi)
KR (1)	KR920000561B1 (fi)
CN (1)	CN1015361B (fi)
AT (1)	ATE76399T1 (fi)
AU (1)	AU602813B2 (fi)
CA (1)	CA1331197C (fi)
CS (1)	CS274502B2 (fi)
DD (1)	DD283772A5 (fi)
DE (1)	DE68901582D1 (fi)
DK (1)	DK172032B1 (fi)
EG (1)	EG19007A (fi)
ES (1)	ES2037418T3 (fi)
FI (1)	FI93541C (fi)
GB (1)	GB8811873D0 (fi)
GR (1)	GR3004968T3 (fi)
HU (1)	HU205067B (fi)
IE (1)	IE60724B1 (fi)
IL (1)	IL90267A (fi)
MX (1)	MX16067A (fi)
MY (1)	MY104735A (fi)
NO (1)	NO173647C (fi)
NZ (1)	NZ229186A (fi)
PH (1)	PH26740A (fi)
PL (1)	PL154813B1 (fi)
PT (1)	PT90584B (fi)
SU (1)	SU1766251A3 (fi)
YU (1)	YU47973B (fi)
ZA (1)	ZA893696B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8812597D0 (en) *	1988-05-27	1988-06-29	Pfizer Ltd	Therapeutic agents
GB8820844D0 (en) *	1988-09-05	1988-10-05	Pfizer Ltd	Therapeutic agents
GB9000725D0 (en) *	1990-01-12	1990-03-14	Pfizer Ltd	Therapeutic agents
ES2081183T3 (es) *	1993-09-22	1996-02-16	Pfizer Res & Dev	Hidrogenacion.
US7468390B2 (en)	2002-01-17	2008-12-23	Novartis Ag	Methods of treatment and pharmaceutical composition
AR057882A1 (es)	2005-11-09	2007-12-26	Novartis Ag	Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en)	2010-11-16	2015-03-31	Novartis Ag	Method of treating contrast-induced nephropathy
DK2887961T3 (da)	2012-08-24	2021-07-19	Novartis Ag	Nep-inhibitorer til behandling af sygdomme, der er kendetegnet ved atrieforstørrelse eller -remodellering
WO2017033128A1 (en)	2015-08-25	2017-03-02	Novartis Ag	Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en)	2015-10-29	2018-11-01	Cadila Healthcare Limited	Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR880007441A (ko) *	1986-12-11	1988-08-27	알렌 제이.스피겔	스피로-치환된 글루타르아미드 이뇨제

1988
- 1988-05-19 GB GB888811873A patent/GB8811873D0/en active Pending
1989
- 1989-05-09 ES ES198989304698T patent/ES2037418T3/es not_active Expired - Lifetime
- 1989-05-09 DE DE8989304698T patent/DE68901582D1/de not_active Expired - Lifetime
- 1989-05-09 EP EP89304698A patent/EP0342850B1/en not_active Expired - Lifetime
- 1989-05-09 AT AT89304698T patent/ATE76399T1/de not_active IP Right Cessation
- 1989-05-11 IL IL90267A patent/IL90267A/xx not_active IP Right Cessation
- 1989-05-16 MY MYPI89000654A patent/MY104735A/en unknown
- 1989-05-17 HU HU892460A patent/HU205067B/hu not_active IP Right Cessation
- 1989-05-17 CA CA000599911A patent/CA1331197C/en not_active Expired - Fee Related
- 1989-05-17 PT PT90584A patent/PT90584B/pt not_active IP Right Cessation
- 1989-05-17 CS CS296589A patent/CS274502B2/cs not_active IP Right Cessation
- 1989-05-17 MX MX1606789A patent/MX16067A/es unknown
- 1989-05-17 SU SU4614002A patent/SU1766251A3/ru active
- 1989-05-17 DD DD89328675A patent/DD283772A5/de not_active IP Right Cessation
- 1989-05-17 ZA ZA893696A patent/ZA893696B/xx unknown
- 1989-05-17 PL PL1989279491A patent/PL154813B1/pl unknown
- 1989-05-18 YU YU102289A patent/YU47973B/sh unknown
- 1989-05-18 JP JP1125479A patent/JPH072699B2/ja not_active Expired - Fee Related
- 1989-05-18 AU AU34904/89A patent/AU602813B2/en not_active Ceased
- 1989-05-18 IE IE161389A patent/IE60724B1/en not_active IP Right Cessation
- 1989-05-18 NO NO892002A patent/NO173647C/no not_active IP Right Cessation
- 1989-05-18 FI FI892386A patent/FI93541C/fi not_active IP Right Cessation
- 1989-05-18 DK DK240889A patent/DK172032B1/da not_active IP Right Cessation
- 1989-05-18 NZ NZ229186A patent/NZ229186A/xx unknown
- 1989-05-19 KR KR1019890006691A patent/KR920000561B1/ko not_active Expired
- 1989-05-19 CN CN89103437A patent/CN1015361B/zh not_active Expired
- 1989-05-21 EG EG25089A patent/EG19007A/xx active
- 1989-06-12 PH PH38643A patent/PH26740A/en unknown
1992
- 1992-06-18 GR GR920401302T patent/GR3004968T3/el unknown

Also Published As

Publication number	Publication date
IE60724B1 (en)	1994-08-10
CA1331197C (en)	1994-08-02
GR3004968T3 (fi)	1993-04-28
PT90584B (pt)	1994-09-30
CN1015361B (zh)	1992-02-05
IL90267A (en)	1993-08-18
CN1037704A (zh)	1989-12-06
FI93541B (fi)	1995-01-13
JPH072699B2 (ja)	1995-01-18
ZA893696B (en)	1990-12-28
DD283772A5 (de)	1990-10-24
PL279491A1 (en)	1989-11-27
MY104735A (en)	1994-05-31
EG19007A (en)	1994-11-30
PL154813B1 (en)	1991-09-30
DE68901582D1 (de)	1992-06-25
ES2037418T3 (es)	1993-06-16
HU205067B (en)	1992-03-30
ATE76399T1 (de)	1992-06-15
HUT53596A (en)	1990-11-28
NO173647C (no)	1994-01-12
DK240889A (da)	1989-11-20
PT90584A (pt)	1989-11-30
IE891613L (en)	1989-11-19
CS274502B2 (en)	1991-04-11
KR920000561B1 (ko)	1992-01-16
EP0342850A1 (en)	1989-11-23
NO892002L (no)	1989-11-20
YU47973B (sh)	1996-08-13
DK172032B1 (da)	1997-09-22
NO173647B (no)	1993-10-04
CS296589A2 (en)	1990-09-12
NZ229186A (en)	1990-10-26
SU1766251A3 (ru)	1992-09-30
YU102289A (en)	1991-06-30
EP0342850B1 (en)	1992-05-20
FI892386L (fi)	1989-11-20
NO892002D0 (no)	1989-05-18
GB8811873D0 (en)	1988-06-22
KR900017993A (ko)	1990-12-20
FI93541C (fi)	1995-04-25
AU602813B2 (en)	1990-10-25
PH26740A (en)	1992-09-28
JPH0222256A (ja)	1990-01-25
IL90267A0 (en)	1989-12-15
MX16067A (es)	1993-10-01
AU3490489A (en)	1989-11-23
DK240889D0 (da)	1989-05-18

Publication	Publication Date	Title
AU6920591A (en)	1991-03-28	Antibacterial agents - II
FI892386A0 (fi)	1989-05-18	Menetelmä enantiomeeristen glutaarihappoamidipohjaisten virtsaneritystä lisäävien yhdisteiden valmistamiseksi
DE69321749D1 (de)	1998-12-03	Verfahren zur Herstellung von Ceftriaxon
ES509782A0 (es)	1983-03-16	Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
ATE30412T1 (de)	1987-11-15	Omega-(2',4'-dihalogenphenylyl)oxoalkansaeuren und verfahren zu ihrer herstellung.
EP0555479A4 (fi)	1994-02-09
DE69229017D1 (de)	1999-06-02	Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
FI883507A0 (fi)	1988-07-26	Naftotiazepinderivat och deras framstaellning.
IE791520L (en)	1980-02-10	Benzene and thiophene-carbothioic acid 2-aminoalkyl ester¹acid salts
FR2590254B1 (fr)	1990-05-25	Procede d'obtention de l'ester ethylique de l'acide apovincanimique
JPS6440458A (en)	1989-02-10	Production of azacycloalkane-2-one compound
PT87904A (pt)	1989-06-30	Processo para a preparacao de acidos aminocarboxilicos biciclicos e de produtos intermediarios para a sua preparacao
ATE132865T1 (de)	1996-01-15	3-anilino-2-hydroxycarbonyl-4-thiophenessigsäur n
JPS55115899A (en)	1980-09-06	3,18-o-cyclotylosin derivative
ATE144257T1 (de)	1996-11-15	Tetrahydro-4-phenylimino-3-thiophenessigsäuren
JPS5559185A (en)	1980-05-02	Cephalosporin analog
FR2630737B1 (fr)	1991-11-08	Procede de preparation d'un derive de l'acide n-acetyl-6-aminohexanoique

Legal Events

Date	Code	Title	Description
1994-12-16	BB	Publication of examined application
2004-08-31	MM	Patent lapsed	Owner name: PFIZER INC.